Valbenazine's Consistent But Weak Effect In Tourette Dismays Neurocrine

 
• By John Davis
  
Gold
The T-Force GOLD Phase IIb results have disappointed Neurocrine • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D